ResMed targets 59-60% gross margins and expanded global reach for AirSense 11 ResMed targets 59-60% gross margins and expanded global reach for AirSense 11 Post Contentrmd, rsmdfRead More You might also be interested in reading Terns Pharmaceuticals GAAP EPS of -$0.26. January 31, 2025 In Mainstream ← Previous post Next post →